Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD: Accurate or Not?

Collins MG, Symonds EL, Bampton PA, Coates PT.

J Am Soc Nephrol. 2019 Oct 9. pii: ASN.2019070710. doi: 10.1681/ASN.2019070710. [Epub ahead of print] No abstract available.

PMID:
31597716
2.

Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients.

Wu Y, Ghaly S, Kerr S, Jackson B, Hanigan K, Martins D, Krishnaprasad K, Mountifield RE, Whiteman DC, Bampton PA, Gearry RB, Radford-Smith GL, Lawrance IC.

Dig Dis Sci. 2019 Sep 6. doi: 10.1007/s10620-019-05818-w. [Epub ahead of print]

PMID:
31493039
3.

A nurse-led model at public academic hospitals maintains high adherence to colorectal cancer surveillance guidelines.

Symonds EL, Simpson K, Coats M, Chaplin A, Saxty K, Sandford J, Young Am GP, Cock C, Fraser R, Bampton PA.

Med J Aust. 2018 Jun 18;208(11):492-496.

PMID:
29902396
4.

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Selvaraj F, Princen F, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Gearry RB, Selby W, Bell SJ, Brown SJ, Connell WR.

J Crohns Colitis. 2018 May 25;12(6):653-661. doi: 10.1093/ecco-jcc/jjy003.

PMID:
29385469
5.

Longitudinal analysis indicates symptom severity influences immune profile in irritable bowel syndrome.

Mavrangelos C, Campaniello MA, Andrews JM, Bampton PA, Hughes PA.

Gut. 2018 Feb;67(2):398-399. doi: 10.1136/gutjnl-2017-314308. Epub 2017 Jun 10. No abstract available.

PMID:
28601848
6.

Serologic antibodies in relation to outcome in postoperative Crohn's disease.

Hamilton AL, Kamm MA, De Cruz P, Wright EK, Selvaraj F, Princen F, Gorelik A, Liew D, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Bell SJ, Brown SJ, Connell WR.

J Gastroenterol Hepatol. 2017 Jun;32(6):1195-1203. doi: 10.1111/jgh.13677.

PMID:
27976801
7.

Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer.

Lindblad M, Bright T, Schloithe A, Mayne GC, Chen G, Bull J, Bampton PA, Fraser RJ, Gatenby PA, Gordon LG, Watson DI.

World J Surg. 2017 Apr;41(4):1023-1034. doi: 10.1007/s00268-016-3819-0.

PMID:
27882416
8.

High Vitamin D-Binding Protein Concentration, Low Albumin, and Mode of Remission Predict Relapse in Crohn's Disease.

Ghaly S, Murray K, Baird A, Martin K, Prosser R, Mill J, Simms LA, Hart PH, Radford-Smith G, Bampton PA, Lawrance IC.

Inflamm Bowel Dis. 2016 Oct;22(10):2456-64. doi: 10.1097/MIB.0000000000000894.

PMID:
27631600
9.

Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease.

Bennett AL, Moore D, Bampton PA, Bryant RV, Andrews JM.

World J Gastroenterol. 2016 Feb 28;22(8):2611-20. doi: 10.3748/wjg.v22.i8.2611.

10.

Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.

De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits S, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.

Aliment Pharmacol Ther. 2015 Oct;42(7):867-79. doi: 10.1111/apt.13353. Epub 2015 Aug 28.

11.

Factors affecting faecal immunochemical test positive rates: demographic, pathological, behavioural and environmental variables.

Symonds EL, Osborne JM, Cole SR, Bampton PA, Fraser RJ, Young GP.

J Med Screen. 2015 Dec;22(4):187-93. doi: 10.1177/0969141315584783. Epub 2015 May 14.

PMID:
25977374
12.

Effect of intestinal resection on quality of life in Crohn's disease.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.

J Crohns Colitis. 2015 Jun;9(6):452-62. doi: 10.1093/ecco-jcc/jjv058. Epub 2015 Apr 8.

PMID:
25855073
13.

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Leach S, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Day AS, Desmond PV, Gearry RB.

Gastroenterology. 2015 May;148(5):938-947.e1. doi: 10.1053/j.gastro.2015.01.026. Epub 2015 Jan 22.

PMID:
25620670
14.

Colonic motor abnormalities in slow transit constipation defined by high resolution, fibre-optic manometry.

Dinning PG, Wiklendt L, Maslen L, Patton V, Lewis H, Arkwright JW, Wattchow DA, Lubowski DZ, Costa M, Bampton PA.

Neurogastroenterol Motil. 2015 Mar;27(3):379-88. doi: 10.1111/nmo.12502. Epub 2015 Jan 3.

PMID:
25557630
15.

Crohn's disease management after intestinal resection: a randomised trial.

De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV.

Lancet. 2015 Apr 11;385(9976):1406-17. doi: 10.1016/S0140-6736(14)61908-5. Epub 2014 Dec 24.

PMID:
25542620
16.

Quantification of in vivo colonic motor patterns in healthy humans before and after a meal revealed by high-resolution fiber-optic manometry.

Dinning PG, Wiklendt L, Maslen L, Gibbins I, Patton V, Arkwright JW, Lubowski DZ, O'Grady G, Bampton PA, Brookes SJ, Costa M.

Neurogastroenterol Motil. 2014 Oct;26(10):1443-57. doi: 10.1111/nmo.12408. Epub 2014 Aug 11.

17.

Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series.

Fazal MW, Doogue MP, Leong RW, Bampton PA, Andrews JM.

BMC Gastroenterol. 2013 Dec 17;13:172. doi: 10.1186/1471-230X-13-172.

18.

Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context.

Bryant RV, Trott MJ, Bennett A, Bampton PA, Moore DJ, Andrews JM.

Intern Med J. 2013 Nov;43(11):1171-6. doi: 10.1111/imj.12272. No abstract available.

PMID:
24237644
19.

Crohn's disease and smoking: is it ever too late to quit?

Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA, Cooke SE, Mahy G, Radford-Smith G, Croft A, Hanigan K.

J Crohns Colitis. 2013 Dec;7(12):e665-71. doi: 10.1016/j.crohns.2013.05.007. Epub 2013 Jun 20.

PMID:
23790611
20.

High resolution colonic manometry--what have we learnt?--A review of the literature 2012.

Bampton PA, Dinning PG.

Curr Gastroenterol Rep. 2013 Jun;15(6):328. doi: 10.1007/s11894-013-0328-2. Review.

PMID:
23709203
21.

Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program.

Cole SR, Tucker GR, Osborne JM, Byrne SE, Bampton PA, Fraser RJ, Young GP.

Med J Aust. 2013 Apr 1;198(6):327-30.

PMID:
23545032
22.

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, B√ľning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH.

Nature. 2012 Nov 1;491(7422):119-24. doi: 10.1038/nature11582.

23.

Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease.

Kennedy NA, Asser TL, Mountifield RE, Doogue MP, Andrews JM, Bampton PA.

Intern Med J. 2013 Mar;43(3):278-86. doi: 10.1111/j.1445-5994.2012.02936.x.

PMID:
22946880
24.
25.

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.

Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH.

J Gastroenterol Hepatol. 2010 Nov;25(11):1732-8. doi: 10.1111/j.1440-1746.2010.06407.x.

PMID:
21039834
26.

Non-endoscopic screening for Barrett's oesophagus.

Bampton PA.

BMJ. 2010 Sep 10;341:c4667. doi: 10.1136/bmj.c4667. No abstract available.

PMID:
20833744
27.

Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia.

Lane JM, Chow E, Young GP, Good N, Smith A, Bull J, Sandford J, Morcom J, Bampton PA, Cole SR.

Gastroenterology. 2010 Dec;139(6):1918-26. doi: 10.1053/j.gastro.2010.08.005. Epub 2010 Aug 16.

PMID:
20723544
28.

Anti-tumour necrosis factor-alpha treatment for perianal Crohn's disease in Australia.

Burger DC, Lawrance IC, Bampton PA, Prosser R, Croft A, Gilshenan K, Radford-Smith GL, Florin TH.

Med J Aust. 2010 Apr 5;192(7):375-7.

PMID:
20367582
29.

Un-promoted issues in inflammatory bowel disease: opportunities to optimize care.

Andrews JM, Mountifield RE, Van Langenberg DR, Bampton PA, Holtmann GJ.

Intern Med J. 2010 Mar;40(3):173-82. doi: 10.1111/j.1445-5994.2009.02110.x. Epub 2009 Oct 22. Review.

PMID:
19849744
30.

Clinical trial: the impact of cyclooxygenase inhibitors on gastrointestinal recovery after major surgery - a randomized double blind controlled trial of celecoxib or diclofenac vs. placebo.

Wattchow DA, De Fontgalland D, Bampton PA, Leach PL, McLaughlin K, Costa M.

Aliment Pharmacol Ther. 2009 Nov 15;30(10):987-98. doi: 10.1111/j.1365-2036.2009.04126.x. Epub 2009 Aug 20.

31.
32.

Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.

Worthley DL, Smith A, Bampton PA, Cole SR, Young GP.

Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1079-83.

PMID:
16957514
33.

Improving surveillance for Barrett's oesophagus.

Bampton PA, Schloithe A, Bull J, Fraser RJ, Padbury RT, Watson DI.

BMJ. 2006 Jun 3;332(7553):1320-3.

34.

Impaired proximal colonic motor response to rectal mechanical and chemical stimulation in obstructed defecation.

Dinning PG, Bampton PA, Kennedy ML, Lubowski DZ, King D, Cook IJ.

Dis Colon Rectum. 2005 Sep;48(9):1777-84.

PMID:
15981057
35.

Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.

Bampton PA, Sandford JJ, Cole SR, Smith A, Morcom J, Cadd B, Young GP.

Gut. 2005 Jun;54(6):803-6.

36.

Abnormal predefecatory colonic motor patterns define constipation in obstructed defecation.

Dinning PG, Bampton PA, Andre J, Kennedy ML, Lubowski DZ, King DW, Cook IJ.

Gastroenterology. 2004 Jul;127(1):49-56.

PMID:
15236171
37.

An audit of argon plasma coagulation, epinephrine injection, and proton-pump infusion therapy in the management of bleeding peptic ulcer disease.

Yap LM, Hagan S, Craig A, Hebbard GG, Young GP, Bampton PA.

Endoscopy. 2004 Apr;36(4):371-2; author reply 372-3. No abstract available.

PMID:
15057696
38.
39.

The proximal colonic motor response to rectal mechanical and chemical stimulation.

Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ.

Am J Physiol Gastrointest Liver Physiol. 2002 Mar;282(3):G443-9.

40.

Prolonged multi-point recording of colonic manometry in the unprepared human colon: providing insight into potentially relevant pressure wave parameters.

Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, Cook IJ.

Am J Gastroenterol. 2001 Jun;96(6):1838-48.

PMID:
11419837
41.

Screening for colorectal cancer will save lives.

Bampton PA, Young GP, John JS.

Med J Aust. 2000 Jun 19;172(12):576-7. No abstract available.

PMID:
10914101
42.

Spatial and temporal organization of pressure patterns throughout the unprepared colon during spontaneous defecation.

Bampton PA, Dinning PG, Kennedy ML, Lubowski DZ, deCarle D, Cook IJ.

Am J Gastroenterol. 2000 Apr;95(4):1027-35.

PMID:
10763955
43.

Relationship between terminal ileal pressure waves and propagating proximal colonic pressure waves.

Dinning PG, Bampton PA, Kennedy ML, Cook IJ.

Am J Physiol. 1999 Nov;277(5):G983-92. doi: 10.1152/ajpgi.1999.277.5.G983.

PMID:
10564104
44.

Basal pressure patterns and reflexive motor responses in the human ileocolonic junction.

Dinning PG, Bampton PA, Kennedy ML, Kajimoto T, Lubowski DZ, de Carle DJ, Cook IJ.

Am J Physiol. 1999 Feb;276(2):G331-40. doi: 10.1152/ajpgi.1999.276.2.G331.

PMID:
9950806
45.

A comparison of transnasal and transoral oesophagogastroduodenoscopy.

Bampton PA, Reid DP, Johnson RD, Fitch RJ, Dent J.

J Gastroenterol Hepatol. 1998 Jun;13(6):579-84.

PMID:
9715399
46.
47.

Aortic and coronary embolism of anaplastic small-cell carcinoma of the lung.

Culver RA, Bampton PA, Bignold LP.

Med J Aust. 1987 Nov 2;147(9):455-6.

PMID:
3670199

Supplemental Content

Loading ...
Support Center